Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shandong Qilu Cell Therapy Engineering Technology Co., Ltd

Clinical trials sponsored by Shandong Qilu Cell Therapy Engineering Technology Co., Ltd, explained in plain language.

Trials to join now! 1

Reprogrammed immune cells target CD30-Positive lymphoma in early trial

Cure Recruiting now

Researchers are testing a treatment called CD30 CAR-T cell therapy in adults with CD30-positive lymphoma that has returned or stopped responding to at least two prior treatments. The therapy involves collecting a patient's T cells, modifying them to recognize and attack CD30-posi…

Early phase 1 • Sponsor: Shandong Qilu Cell Therapy Engineering Technology Co., Ltd • Aim: Cure

Last updated Sep 22, 2026 01:00 UTC